AstraZeneca swung to 4Q loss despite revenue rise; expects $2.1 bln restructuring charge | Mint
Drug maker Alexion to close R.I. plant
Is Alexion's Boston Move A Smoke Screen? – Hartford Courant
New Haven's Alexion Cutting More Than 200 Jobs | Connecticut Public
Alexion closing RI manufacturing facility, 250 losing jobs
Alexion's splashy Boston HQ move sets stage for local dealmaking - Boston Business Journal
Activist Investor Urges Alexion to Sell Itself or Else | BioSpace
Alexion inks deal to acquire Achillion for $930M upfront | Fierce Biotech
Alexion Pharmaceuticals Will Move Headquarters To Boston | Connecticut Public
Alexion Restructuring, Moving Headquarters to Boston – ISPE Boston
Covid vaccine maker AstraZeneca says 2021 profit dives | Mossel Bay Advertiser
AstraZeneca's Alexion agrees on $775m settlement with Chugai for Ultomiris - PMLiVE
Alexion Exits New Haven For Boston, Agrees To Repay Millions In State Aid – Hartford Courant
AstraZeneca earmarks $68.7M for two Alexion plants in Ireland
BioCentury - Alexion vet Goff to lead Agios as CEO; Fouse becoming chair
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven | Fierce Biotech
AstraZeneca's Alexion hopes to extend dominance in PNH
Alexion to close Lexington facility as part of Boston HQ move - Boston Business Journal
Alexion Pharmaceuticals, Inc. 2017 Q3 - Results - Earnings Call Slides (NASDAQ:ALXN) | Seeking Alpha
Alexion scraps R&D programs, lays off staff after setbacks | Fierce Biotech
JPM: Alexion gives an updated look at what AstraZeneca's getting for $39B | Fierce Pharma
Alexion to Acquire Wilson Therapeutics | Business Wire
Alexion to Restructure Operations, to Lower Headcount by 20%
Alexion plots hundreds of layoffs, HQ move in sweeping corporate revamp | Fierce Pharma
Alexion to Restructure Operations, to Lower Headcount by 20%
